Innovating Lung Cancer Immunotherapy: Dr. Kellie Smith on T-Cells and Scientific Leadership @Labroots
Innovating Lung Cancer Immunotherapy: Dr. Kellie Smith on T-Cells and Scientific Leadership  @Labroots
Uploaded January 2026 | Updated November 2026, 2 days ago
Dr. Kellie Smith is an Associate Professor of Oncology in the Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins School of Medicine. In this interview, Dr. Smith shares how she came to study science and specialize in T-cell immunology and immunotherapy. She also discusses how she developed an original assay for detecting anti-tumor immune responses in specific types of lung cancer, called MANASCORE. She also shares some details about the goal of comprehensively understanding immunotherapy-resistant immune cells.  Dr. Smith reveals the basic thought process that led her to a focus on integrating multi-omics technologies to study tumor-reactive T cells in the setting of various cancer types, with a specific focus on lung cancer; what brought her to Johns Hopkins, and how remaining at the institution throughout her career been an asset to her research.   






In a field that is highly technical and requires sustained, years-long dedication that some people could find draining or otherwise unrewarding — the big Hollywood moments are presumably rare. Dr. Smith describes how she paces herself, determines benchmarks, and frames big-picture questions that structure her work.   






Finally, scientists have long worked at the center of the tension between advancing (empirical) knowledge, and the realities of socio-political and cultural pressures. Dr. Smith discusses how scientists should grapple with the current tension.






Episode Resources:

• Profile Page, Johns Hopkins Medicine (profiles.hopkinsmedicine.org/provider/kellie-n-smith/2777132)
• Google Scholar Page (scholar.google.com/citations?user=6j1rcL4AAAAJ&hl=en)
• Keynote Presentation: Immunogenomic Characterization of Tumor-Reactive TIL in Lung Cancers w/ Live Q&A (labroots.com/webinar/keynote-presentation-immunogenomic-characterization-tumor-reactive-til-lung-cancers-w-live-q-a)
• Keynote Presentation: Characterizing the phenotype, function, and spatial interactions of tumor-reactive TIL (labroots.com/webinar/keynote-presentation-characterizing-phenotype-function-spatial-interactions-tumor-reactive-til)





Connect & explore more: Visit The Life of Her Mind (labroots.com/podcast-series/life-of-her-mind) to listen, share, and access links and resources. Check out Labroots scholarship opportunities here (labroots.com/scholarships) . Submit a scientific poster to be featured in our event(s) here (labroots.com/posters) . 
Innovating Lung Cancer Immunotherapy: Dr. Kellie Smith on T-Cells and Scientific LeadershipHealthy Aging in human cohorts: Proteomic Signatures for various human organ tissues and correspondgThe Role of Multiplex Assays in Cancer DetectionEvolving Respiratory Viral Testing in the Post-Pandemic Era: Clinical and Lab PerspectivesIsolation to Innovation: High-Molecular Weight DNA for Long-Read SuccessLife on Ice in a Thawing World: Pushing Microbes and Researchers to the ExtremeAge, Ageing and the ProteomeA Question of Quality: Developing a Heparin Therapeutic Range Utilizing the aPTTPanel discussion Proteomics Essentials: A Roundtable on the Key ConceptsCustom Solutions in Genotyping: Insights from Plant and Animal ResearchAdvancing Cancer Research with Tools for Liquid BiopsyClassification of Myeloid Neoplasms: Navigating ICC and WHO-HAEM5 Differences
Labroots |

Innovating Lung Cancer Immunotherapy: Dr. Kellie Smith on T-Cells and Scientific Leadership

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER